With the aim to explore the potentiality of new chemical scaffolds for the design of new antimalarials, a set of new indeno[2,1-c]quinolines bearing different basic heads has been synthesized and tested in vitro against chloroquine sensitive (CQ-S) and chloroquine resistant (CQ-R) strains of Plasmodium falciparum. Most of the synthesized compounds exhibited a moderate antiplasmodial activity, inhibiting the growth of both CQ-S and CQ-R strains of P. falciparum with IC50 ranging from 0.24 to 6.9μM and with a very low resistance index. The most potent compounds (1.2-1.3-fold the CQ on the W-2 strain) can be considered as promising 'lead compounds' to be further optimized to improve efficacy and selectivity against Plasmodia.

Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives / A. Barteselli, S. Parapini, N. Basilico, D. Mommo, A. Sparatore. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - 22:21(2014 Nov 01), pp. 5757-5765. [10.1016/j.bmc.2014.09.040]

Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives

A. Barteselli
Primo
;
S. Parapini
Secondo
;
N. Basilico;A. Sparatore
2014

Abstract

With the aim to explore the potentiality of new chemical scaffolds for the design of new antimalarials, a set of new indeno[2,1-c]quinolines bearing different basic heads has been synthesized and tested in vitro against chloroquine sensitive (CQ-S) and chloroquine resistant (CQ-R) strains of Plasmodium falciparum. Most of the synthesized compounds exhibited a moderate antiplasmodial activity, inhibiting the growth of both CQ-S and CQ-R strains of P. falciparum with IC50 ranging from 0.24 to 6.9μM and with a very low resistance index. The most potent compounds (1.2-1.3-fold the CQ on the W-2 strain) can be considered as promising 'lead compounds' to be further optimized to improve efficacy and selectivity against Plasmodia.
Indeno[2,1-c]quinoline; Antimalarial activity; Plasmodium falciparum; Antiplasmodial activity
Settore CHIM/08 - Chimica Farmaceutica
Settore MED/04 - Patologia Generale
Settore MED/07 - Microbiologia e Microbiologia Clinica
1-nov-2014
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0968089614006944-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 953.1 kB
Formato Adobe PDF
953.1 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/243014
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 13
social impact